Our mission is to ensure the generation of accurate and precise findings.
Please enter subscribe form shortcode
Please enter instagram feed shortcode
Expert guidance to align nonclinical development with clinical, regulatory, and CMC objectives, backed by risk assessment and scientific interpretation.
Design, implementation, and monitoring of pharmacology, toxicology, and ADME studies, including CRO qualification and GLP oversight.
Authoring and QC of INDs, CTAs, NDAs, BLAs, MAAs, Investigator Brochures, summaries, and labeling with GLP/ICH compliance and SEND support.
Strategic support and active participation in health authority interactions to ensure your nonclinical data is positioned clearly and defensibly.
Independent program management, CRO oversight, literature review, data integration, and milestone tracking to ensure quality and efficiency.
Safety evaluation, impurity/leachable assessments, product quality review, and risk mitigation planning for devices and combination products.
